Inducible Silencing of RepID in Melanoma
Corresponding Organization : Center for Cancer Research
Other organizations : In Silico Biosciences (United States), Cornell University
Variable analysis
- Silencing of endogenous RepID using an inducible shRNA-expressing vector, pSingle-tTS-shRNA (Clontech)
- Conditional expression of shRNA directed against RepID in 2451 13T melanoma cells
- Stable clones were selected
- Cells conditionally expressing shRNA directed against RepID were induced (or not) with doxycycline for 16 days
- Positive control: Cells conditionally expressing shRNA directed against RepID induced with doxycycline for 16 days
- Negative control: Cells conditionally expressing shRNA directed against RepID not induced with doxycycline for 16 days
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!